Luigi Addario

521 total citations
12 papers, 328 citations indexed

About

Luigi Addario is a scholar working on Epidemiology, Hepatology and Physiology. According to data from OpenAlex, Luigi Addario has authored 12 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 11 papers in Hepatology and 2 papers in Physiology. Recurrent topics in Luigi Addario's work include Liver Disease Diagnosis and Treatment (11 papers), Liver Disease and Transplantation (7 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). Luigi Addario is often cited by papers focused on Liver Disease Diagnosis and Treatment (11 papers), Liver Disease and Transplantation (7 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). Luigi Addario collaborates with scholars based in Italy, United Kingdom and Czechia. Luigi Addario's co-authors include G.G. Di Costanzo, F. Lampasi, Giovanni Tritto, M.T. Tartaglione, M. De Luca, Alfonso Galeota Lanza, Francesco Picciotto, Antonio Ascione, O. Cuomo and Fulvio Calise and has published in prestigious journals such as Journal of Hepatology, Journal of Gastroenterology and Hepatology and European Journal of Gastroenterology & Hepatology.

In The Last Decade

Luigi Addario

12 papers receiving 319 citations

Peers

Luigi Addario
Areen Said United States
Morven Cunningham United Kingdom
Olcay Çubukçu United States
Juri Fuchs Germany
Areen Said United States
Luigi Addario
Citations per year, relative to Luigi Addario Luigi Addario (= 1×) peers Areen Said

Countries citing papers authored by Luigi Addario

Since Specialization
Citations

This map shows the geographic impact of Luigi Addario's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luigi Addario with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luigi Addario more than expected).

Fields of papers citing papers by Luigi Addario

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luigi Addario. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luigi Addario. The network helps show where Luigi Addario may publish in the future.

Co-authorship network of co-authors of Luigi Addario

This figure shows the co-authorship network connecting the top 25 collaborators of Luigi Addario. A scholar is included among the top collaborators of Luigi Addario based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luigi Addario. Luigi Addario is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Luca, M. De, Luigi Addario, Michele Imparato, et al.. (2021). Adipopenia Is the Rapid Screening Tool that Best Predicts Mortality in Patients with Decompensated Cirrhosis: Results of a Prospective Study. Journal of Gastrointestinal and Liver Diseases. 30(1). 94–102. 5 indexed citations
2.
Luca, M. De, Luigi Addario, Michele Imparato, et al.. (2020). Adipopenia, among the nutritional parameters, is the one that best correlates with mortality in decompensated cirrhotic patients: results of a prospective study. Digestive and Liver Disease. 52. e61–e61. 1 indexed citations
3.
Costanzo, G.G. Di, Raffaella Tortora, Filomena Morisco, et al.. (2016). Impact of Diabetes on Outcomes of Sorafenib Therapy for Hepatocellular Carcinoma. Targeted Oncology. 12(1). 61–67. 18 indexed citations
4.
Costanzo, G.G. Di, G. de Stefano, Raffaella Tortora, et al.. (2015). Sorafenib off-target effects predict outcomes in patients treated for hepatocellular carcinoma. Future Oncology. 11(6). 943–951. 26 indexed citations
5.
Costanzo, G.G. Di, Raffaella Tortora, M. De Luca, et al.. (2014). Radiofrequency ablation versus laser ablation for the treatment of small hepatocellular carcinoma in cirrhosis: A randomized trial. Journal of Gastroenterology and Hepatology. 30(3). 559–565. 52 indexed citations
7.
Addario, Luigi, et al.. (2010). Preserved liver function, portal thrombosis and absence of oesophageal varices are risk factors for metastasis of hepatocellular carcinoma. Digestive and Liver Disease. 43(4). 319–324. 20 indexed citations
9.
Costanzo, G.G. Di, M. De Luca, Giovanni Tritto, et al.. (2008). Effect of alcohol, cigarette smoking, and diabetes on occurrence of hepatocellular carcinoma in patients with transfusion-acquired hepatitis C virus infection who develop cirrhosis. European Journal of Gastroenterology & Hepatology. 20(7). 674–679. 18 indexed citations
10.
Addario, Luigi, Giuseppe Scaglione, Giovanni Tritto, et al.. (2006). Prognostic value of quantitative liver function tests in viral cirrhosis: a prospective study. European Journal of Gastroenterology & Hepatology. 18(7). 713–720. 14 indexed citations
11.
Picciotto, Francesco, Giovanni Tritto, Alfonso Galeota Lanza, et al.. (2006). Sustained virological response to antiviral therapy reduces mortality in HCV reinfection after liver transplantation. Journal of Hepatology. 46(3). 459–465. 151 indexed citations
12.
Costanzo, G.G. Di, Giovanni Raimondo, Giuseppe Longo, et al.. (1998). Efficacy of high dose of recombinant alpha 2b interferon on long term response in chronic hepatitis C and cirrhosis: prospective randomized multicentre study.. PubMed. 30(5). 517–23. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026